Table 2.
DRD2 in breast and lung cancers
| System | Agents/targets | Results/effect | |
|---|---|---|---|
| Breast cancer | |||
| MCF-7 cells | bromocriptine (DRD2 agonist) | proliferation ↓ | [31] |
| Xenograft mice | sulpiride (DRD2 antagonist) | anticancer effect | [32] |
| MDA-MB-231, MCF-7, and SKBR3 cells | Mir-4301 (DRD2 downregulation) | apoptosis | [27] |
| MDA-MB231 and BT549 cells/Mice | DRD2 expression | apoptosis | [33] |
| Lung cancer | |||
| Human | SNP study | DRD2 and nicotine addiction | [34] |
| Xenograft mice | bromocriptine | proliferation ↓ | [35] |
| Xenograft mice | DRD2 agonist | Cancer angiogenesis ↓ | [36] |
| NSCLC | DRD2 overexpression | Tumor cell growth ↓ | [38] |